RA Capital Management - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
RA Capital Management ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$41,993,000
-69.2%
2,210,145
-46.1%
0.74%
-60.8%
Q3 2021$136,392,000
+5.2%
4,098,332
+22.6%
1.89%
-9.2%
Q2 2021$129,665,000
-42.0%
3,342,743
-27.9%
2.08%
-38.2%
Q1 2021$223,462,000
-50.5%
4,636,146
-46.6%
3.37%
-46.6%
Q4 2020$451,818,000
+91.3%
8,685,471
-1.6%
6.32%
+46.2%
Q3 2020$236,180,000
-5.2%
8,825,849
-31.0%
4.32%
-11.0%
Q2 2020$249,119,000
+143.7%
12,788,457
+23.1%
4.85%
+50.3%
Q1 2020$102,212,000
-6.8%
10,387,411
+5.1%
3.23%
-2.9%
Q4 2019$109,672,000
+183.9%
9,880,323
+43.6%
3.33%
+44.5%
Q3 2019$38,633,000
-35.1%
6,880,3230.0%2.30%
-27.9%
Q2 2019$59,515,000
-9.7%
6,880,323
-16.1%
3.20%
+12.4%
Q1 2019$65,915,000
+96.1%
8,198,3370.0%2.84%
+45.2%
Q4 2018$33,613,000
-26.8%
8,198,3370.0%1.96%
-20.3%
Q3 2018$45,911,000
-18.4%
8,198,337
+91.6%
2.45%
-32.8%
Q2 2018$56,266,000
+60.3%
4,278,796
+73.1%
3.65%
+35.8%
Q1 2018$35,107,000
+323.2%
2,472,344
+253.2%
2.69%
+259.1%
Q3 2017$8,295,000
+17.9%
700,0000.0%0.75%
-7.2%
Q2 2017$7,035,000
-13.7%
700,0000.0%0.81%
-19.3%
Q1 2017$8,155,000
+74.6%
700,000
-30.3%
1.00%
+51.1%
Q4 2016$4,670,000
-87.0%
1,004,314
-78.3%
0.66%
-82.1%
Q3 2016$35,845,000
+30.5%
4,631,114
+2.2%
3.70%
-2.7%
Q2 2016$27,462,000
-28.9%
4,531,7140.0%3.80%
-23.0%
Q1 2016$38,610,000
+15.0%
4,531,714
+61.1%
4.94%
+48.6%
Q4 2015$33,568,000
+6.6%
2,813,779
-9.9%
3.32%
-26.6%
Q3 2015$31,495,000
-42.5%
3,124,480
-5.4%
4.52%
-17.9%
Q2 2015$54,784,000
+13.2%
3,302,213
+5.7%
5.51%
+14.7%
Q1 2015$48,377,000
-8.8%
3,125,149
-6.7%
4.80%
-15.8%
Q4 2014$53,071,000
+140.8%
3,350,449
+62.2%
5.70%
+119.0%
Q3 2014$22,040,000
+628.8%
2,065,571
+244.3%
2.60%
+724.1%
Q3 2013$3,024,000600,0000.32%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,890,000$15,800,4005.14%
Ghost Tree Capital, LLC 1,000,000$8,360,0002.75%
Soleus Capital Management, L.P. 2,884,382$24,113,4342.22%
M28 Capital Management LP 216,600$1,810,7762.08%
Paradigm Biocapital Advisors LP 3,619,015$30,254,9652.05%
683 Capital Management, LLC 1,350,000$11,286,0000.88%
Parkwood LLC 165,414$6,0810.66%
Spotlight Asset Group, Inc. 79,000$660,4400.60%
Pier Capital, LLC 392,709$3,283,0470.53%
Quantum Private Wealth, LLC 91,081$761,4380.36%
View complete list of TG THERAPEUTICS INC shareholders